While HTR1A, HTR2A, and HTR7 are known targets of lurasidone, MAOB, HTR3A, SLC18A2, and HTR1B were identified for the first time as targets of lurasidone potentially involved in its associated induction of acute manic episodes in people with bipolar depression. The gene discussed is HTR2A; the disease is bipolar disorder.